Literature DB >> 23365097

Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.

Mariam B Totonchy1, Deborah Tamura, Matthew S Pantell, Christopher Zalewski, Porcia T Bradford, Saumil N Merchant, Joseph Nadol, Sikandar G Khan, Raphael Schiffmann, Tyler Mark Pierson, Edythe Wiggs, Andrew J Griffith, John J DiGiovanna, Kenneth H Kraemer, Carmen C Brewer.   

Abstract

To assess the role of DNA repair in maintenance of hearing function and neurological integrity, we examined hearing status, neurological function, DNA repair complementation group and history of acute burning on minimal sun exposure in all patients with xeroderma pigmentosum, who had at least one complete audiogram, examined at the National Institutes of Health from 1971 to 2012. Seventy-nine patients, aged 1-61 years, were diagnosed with xeroderma pigmentosum (n = 77) or xeroderma pigmentosum/Cockayne syndrome (n = 2). A total of 178 audiograms were included. Clinically significant hearing loss (>20 dB) was present in 23 (29%) of 79 patients. Of the 17 patients with xeroderma pigmentosum-type neurological degeneration, 13 (76%) developed hearing loss, and all 17 were in complementation groups xeroderma pigmentosum type A or type D and reported acute burning on minimal sun exposure. Acute burning on minimal sun exposure without xeroderma pigmentosum-type neurological degeneration was present in 18% of the patients (10/55). Temporal bone histology in a patient with severe xeroderma pigmentosum-type neurological degeneration revealed marked atrophy of the cochlear sensory epithelium and neurons. The 19-year mean age of detection of clinically significant hearing loss in the patients with xeroderma pigmentosum with xeroderma pigmentosum-type neurological degeneration was 54 years younger than that predicted by international norms. The four frequency (0.5/1/2/4 kHz) pure-tone average correlated with degree of neurodegeneration (P < 0.001). In patients with xeroderma pigmentosum, aged 4-30 years, a four-frequency pure-tone average ≥10 dB hearing loss was associated with a 39-fold increased risk (P = 0.002) of having xeroderma pigmentosum-type neurological degeneration. Severity of hearing loss parallels neurological decline in patients with xeroderma pigmentosum-type neurological degeneration. Audiometric findings, complementation group, acute burning on minimal sun exposure and age were important predictors of xeroderma pigmentosum-type neurological degeneration. These results provide evidence that DNA repair is critical in maintaining neurological integrity of the auditory system.

Entities:  

Mesh:

Year:  2013        PMID: 23365097      PMCID: PMC3562077          DOI: 10.1093/brain/aws317

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  40 in total

Review 1.  Modulation of presbycusis: current status and future directions.

Authors:  J F Willott; T Hnath Chisolm; J J Lister
Journal:  Audiol Neurootol       Date:  2001 Sep-Oct       Impact factor: 1.854

2.  Trichothiodystrophy with severe cardiac and neurological involvement in two sisters.

Authors:  S P Toelle; E Valsangiacomo; E Boltshauser
Journal:  Eur J Pediatr       Date:  2001-12       Impact factor: 3.183

3.  Controlling the efficiency of excision repair.

Authors:  P C Hanawalt
Journal:  Mutat Res       Date:  2001-02-25       Impact factor: 2.433

Review 4.  Xeroderma pigmentosum--bridging a gap between clinic and laboratory.

Authors:  S Moriwaki; K H Kraemer
Journal:  Photodermatol Photoimmunol Photomed       Date:  2001-04       Impact factor: 3.135

Review 5.  Mutation in mitochondrial DNA as a cause of presbyacusis.

Authors:  James O Pickles
Journal:  Audiol Neurootol       Date:  2004 Jan-Feb       Impact factor: 1.854

6.  Adult-onset xeroderma pigmentosum neurological disease--observations in an autopsy case.

Authors:  J H Robbins; K H Kraemer; S N Merchant; R A Brumback
Journal:  Clin Neuropathol       Date:  2002 Jan-Feb       Impact factor: 1.368

Review 7.  Cockayne syndrome and xeroderma pigmentosum.

Authors:  I Rapin; Y Lindenbaum; D W Dickson; K H Kraemer; J H Robbins
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

Review 8.  Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases.

Authors:  Y Lindenbaum; D Dickson; P Rosenbaum; K Kraemer; I Robbins; I Rapin
Journal:  Eur J Paediatr Neurol       Date:  2001       Impact factor: 3.140

Review 9.  Molecular mechanisms of age-related hearing loss.

Authors:  Michael D Seidman; Nadir Ahmad; Uma Bai
Journal:  Ageing Res Rev       Date:  2002-06       Impact factor: 10.895

10.  Accelerated loss of hearing and vision in the DNA-repair deficient Ercc1(δ/-) mouse.

Authors:  Marcella Spoor; A Paul Nagtegaal; Yanto Ridwan; Nils Z Borgesius; Bart van Alphen; Ingrid van der Pluijm; Jan H J Hoeijmakers; Maarten A Frens; J Gerard G Borst
Journal:  Mech Ageing Dev       Date:  2012-01-12       Impact factor: 5.432

View more
  22 in total

Review 1.  Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients.

Authors:  Deborah Tamura; John J DiGiovanna; Sikandar G Khan; Kenneth H Kraemer
Journal:  Photodermatol Photoimmunol Photomed       Date:  2014-02-19       Impact factor: 3.135

2.  Macular and Retinal Nerve Fibre Layer Thinning in Xeroderma Pigmentosum: A Cross-sectional Study.

Authors:  Anna M Gruener; Ana M S Morley
Journal:  Neuroophthalmology       Date:  2018-05-22

3.  Noise Stress Induces an Epidermal Growth Factor Receptor/Xeroderma Pigmentosum-A Response in the Auditory Nerve.

Authors:  O'neil W Guthrie
Journal:  J Histochem Cytochem       Date:  2017-01-05       Impact factor: 2.479

Review 4.  Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.

Authors:  Michael F Walsh; Vivian Y Chang; Wendy K Kohlmann; Hamish S Scott; Christopher Cunniff; Franck Bourdeaut; Jan J Molenaar; Christopher C Porter; John T Sandlund; Sharon E Plon; Lisa L Wang; Sharon A Savage
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

Review 5.  Chemiexcitation and Its Implications for Disease.

Authors:  Douglas E Brash; Leticia C P Goncalves; Etelvino J H Bechara
Journal:  Trends Mol Med       Date:  2018-05-08       Impact factor: 11.951

6.  Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.

Authors:  Robert N Rainey; Sum-Yan Ng; Juan Llamas; Gijsbertus T J van der Horst; Neil Segil
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

7.  Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration.

Authors:  Lucas M Viana; Mohammad Seyyedi; Carmen C Brewer; Christopher Zalewski; John J DiGiovanna; Deborah Tamura; Mariam Totonchy; Kenneth H Kraemer; Joseph B Nadol
Journal:  Otol Neurotol       Date:  2013-09       Impact factor: 2.311

Review 8.  Cochlear histopathology in human genetic hearing loss: State of the science and future prospects.

Authors:  Krishna Bommakanti; Janani S Iyer; Konstantina M Stankovic
Journal:  Hear Res       Date:  2019-08-19       Impact factor: 3.208

9.  Genetic variation in APE1 gene promoter is associated with noise-induced hearing loss in a Chinese population.

Authors:  Huanxi Shen; Jianrui Dou; Lei Han; Ying Bai; Qian Li; Zhiqiang Hong; Jian Shi; Hengdong Zhang; Feng Zhang; Cheng Du; Zhimin Tong; Baoli Zhu
Journal:  Int Arch Occup Environ Health       Date:  2015-10-27       Impact factor: 3.015

Review 10.  Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.

Authors:  Kenneth H Kraemer; John J DiGiovanna
Journal:  Photochem Photobiol       Date:  2015-01-08       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.